Publications des scientifiques de l'IRD

Aubry F., Nougairede A., Gould E. A., de Lamballerie Xavier. (2015). Flavivirus reverse genetic systems, construction techniques and applications : a historical perspective. Antiviral Research, 114, p. 67-85. ISSN 0166-3542.

Titre du document
Flavivirus reverse genetic systems, construction techniques and applications : a historical perspective
Année de publication
2015
Type de document
Article référencé dans le Web of Science WOS:000348960300009
Auteurs
Aubry F., Nougairede A., Gould E. A., de Lamballerie Xavier
Source
Antiviral Research, 2015, 114, p. 67-85 ISSN 0166-3542
The study of flaviviruses, which cause some of the most important emerging tropical and sub-tropical human arbovirus diseases, has greatly benefited from the use of reverse genetic systems since its first development for yellow fever virus in 1989. Reverse genetics technology has completely revolutionized the study of these viruses, making it possible to manipulate their genomes and evaluate the direct effects of these changes on their biology and pathogenesis. The most commonly used reverse genetics system is the infectious clone technology. Whilst flavivirus infectious clones provide a powerful tool, their construction as full-length cDNA molecules in bacterial vectors can be problematic, laborious and time consuming, because they are often unstable, contain unwanted induced substitutions and may be toxic for bacteria due to viral protein expression. The incredible technological advances that have been made during the past 30 years, such as the use of PCR or new sequencing methods, have allowed the development of new approaches to improve preexisting systems or elaborate new strategies that overcome these problems. This review summarizes the evolution and major technical breakthroughs in the development of flavivirus reverse genetics technologies and their application to the further understanding and control of these viruses and their diseases.
Plan de classement
Entomologie médicale / Parasitologie / Virologie [052]
Identifiant IRD
PAR00012825
Contact